Figure 2

Before and after propensity matching, Kaplan-Meier DMFS and OS curves for the two treatment group in patients with WHO histological type IIb. (A,B) Distant metastasis-free survival; (C,D) overall survival; IC + CCRT, induction chemotherapy plus concurrent chemoradiotherapy; CCRT, concurrent chemoradiotherapy.